Filing Details

Accession Number:
0000899243-22-018409
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-05-17 16:33:05
Reporting Period:
2022-05-13
Accepted Time:
2022-05-17 16:33:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1521036 Lantheus Holdings Inc. LNTH In Vitro & In Vivo Diagnostic Substances (2835) 352318913
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1801395 Paul Blanchfield C/O Lantheus Holdings, Inc.
331 Treble Cove Road
North Billerica MA 01862
Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-05-13 2,285 $60.95 74,146 No 4 S Direct
Common Stock Disposition 2022-05-13 785 $0.00 785 No 4 G Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 G Direct
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2022.